To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Salla disease (or Finnish type sialuria) is a syndrome leading to early physical impairment and mental retardation. This is due to a mutation in chromosome 6 (a recessive allele in the gene SLC17A5 the locus of which is 6q14-15). This gene codes for sialin, a lysosomal membrane protein that transports the charged sugar, N-acetylneuraminic acid (sialic acid), out of lysosomes. The mutation causes sialic acid to build up in the cells.
Additional recommended knowledge
First described by P Aula et al. in 1979, Salla disease is named after Salla, a municipality in Finnish Lapland. It is one of nearly 40 diseases that make up the Finnish disease heritage. The majority of 100 Salla disease patients in Finland live in Salla or neighboring municipalities; there are maybe 30-40 patients living abroad, majority of them (one source says 27) in Sweden.
Individuals with Salla disease may present with nystagmus in the first months of life as well as hypotonia and cognitive impairment. The most severely impaired children do not walk or acquire language, but the typical patient learns to walk and speak and has normal life expectancy. The MRI shows arrested or delayed myelination.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Salla_disease". A list of authors is available in Wikipedia.|